Health product recall

Trilogy EVO and EV300

Last updated

Summary

Product
Trilogy EVO and EV300
Issue
Medical devices - Device compatibility
What to do

Contact the manufacturer if you require additional information. 

Audience
Healthcare

Affected products

Affected products

Lot or serial number

Model or catalog number

Trilogy EVO, Canada

All lots.

CA2110X12B

Trilogy EVO, O2, Canada EV300

All lots.

CA2200X12B

Issue

Philips Respironics has become aware that Trilogy EVO and Trilogy EV300 devices do not comply with the obstruction alarm requirements specified within ISO 80601-2-12 clause 201.12.4.108 and ISO 80601-2-72 clause 201.12.4.107.  

The standards specify that the maximum delay from obstruction to alarm shall be no more than 2 breath cycles or 5 seconds, whichever is greater. The current obstruction alarm delay for these devices has been measured up to 65 seconds in certain bench test conditions.  This is a delay potentially 60 seconds greater than required by the standards.

Recall start date: July 1, 2024

Additional information

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Anaesthesiology
Companies

Respironics Inc. Also Trading As Philips Rs North America LLC

1001 Murry Ridge Lane, Murrysville, Pennsylvania, United States, 15668

Published by
Health Canada
Audience
Healthcare
Recall class
Type II
Identification number
RA-75855

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe